Elucidating the Structural Requirements of Novel Pazopanib Derivatives towards Tyrosine Kinase Inhibitory Activity through Classical Hansch and De-Novo Approach
Abstract
Quantitative structure–activity relationship (QSAR) and Molecular modeling study have been performed on a series of novel Pazopanib derivatives by using the Mixed Hansch Fujita-Ban approach and employing AM1 calculations in docking study which give insight into the structural requirements of the derivatives towards inhibitory activity against VEGFR-2, PDGFR-α and c-kit tyrosine kinases enzymes. Evaluation of the predictive ability of the resulting models is carried out by using ‘Leave-one-out’ (LOO) method of cross validation. There is a remarkable agreement in the results of both the approaches. From the QSAR study it can be inferred that methyl substitution at 5th position of the terminal benzene ring and hydrophobicity play a key role in kinase inhibitory activity. Potential binding sites were elucidated by docking study. Docking simulations was performed through Molegro Virtual Docker (MVD) for lead optimization of compound as protein tyrosine kinase inhibitors.
DOI
https://doi.org/10.22270/jddt.v7i7.1620References
Srinivasan M, Trivedi SG, Tyrosine kinase inhibitors in cancer therapy, Clin Biochem, 2004, 37, 618-635.
Levitzki A, Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents, P&T, 1999, 82, 231-239.
Levitzki A, Gazit A, Tyrosine kinase inhibition: an approach to drug development, Science, 1995, 267, 1782-1788.
Bari SB, Adhikari S, Surana SJ, Tyrosine Kinase Receptor Inhibitors: A New Target for Anticancer Drug Development, JPST, 2012, 1, 36-45.
Dengke L, Haofei Q, Ligong C, Bingni L, Xinran W, Synthesis and biological evaluation of novel pazopanib derivatives as antitumor agents, BMCL, 2014, 24, 1108-1110.
Published
Abstract Display: 276
PDF Downloads: 507 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.